Abstracts & Presentations
International Conferences
2012 International Conferences
(By conference, by month, by author)
11th International Congress on Drug Therapy in HIV Infection, Glasgow,
Scotland, November 2012
Lundgren J, When to start ART? Not so fast vis-a-vis evidence and practice
(invited talk) --
Slides
XIX International AIDS Conference, Washington DC, July 2012
Borges Á et al, Factors associated with elevated D-dimer levels in
HIV-positive individuals --
Abstract |
Poster
Mannheimer S et al, Suboptimal self-reported antiretroviral therapy (ART)
adherence associated with certain protease inhibitors and virologic
rebound in the SMART study --
Abstract |
Poster
Satellite Session: Five Years After the SMART Study, a Paradigm-shifting
Trial --
Agenda
- El-Sadr W, HIV treatment research in 2002 and then SMART --
Slides
- Phillips A, HIV and serious non-AIDS conditions --
Slides
- Baker J, Importance of inflammation and coagulation for risk of serious
non-AIDS: results of biomarker studies --
Slides
- Jeffreys R, A community perspective on SMART --
Slides
- Lundgren J, The START trial: on the shoulders of SMART --
Slides
14th International Workshop on Co-morbidities and Adverse Drug Reactions
in HIV, Washington DC, July 2012
Borges AH et al (Lundgren JD, presenting), Predicting risk of cancer
during HIV infection: the role of inflammatory and coagulation biomarkers --
Abstract |
Slides
16th International Workshop on HIV Observational Databases, Athens,
Greece, March 2012
Achhra AC et al, Reclassification of risk of death using a novel biomarker
in a cohort of treated HIV-infected individuals --
Abstract |
Slides
O'Connor J et al, Suboptimal adherence is a strong predictor of viral
rebound in participants on combination antiretroviral therapy (ART) in
SMART --
Abstract |
Slides
19th Conference on Retroviruses and Opportunistic Infections, Seattle,
Washington, March 2012
Baker JV et al, HIV replication, inflammation, and the effect of starting ART
on plasma ADMA, a novel marker of endothelial dysfunction --
Abstract |
Poster (with themed discussion) |
Slides
Bjerk S et al, Bacterial pneumonia-CRP, but not pulmonary biomarkers, predicts
bacterial pneumonia events: the SMART trial --
Abstract |
Poster
Limou S et al, APOL1 and MYH9 renal risk variants predict kidney function in
treated HIV+ subjects with African ancestry enrolled in the SMART study --
Abstract |
Poster
Lucas G et al, Baseline creatinine-based eGFR and CC as predictors of clinical
events: SMART study --
Abstract |
Poster
Neuhaus J et al (Ross M, presenter), Do inflammatory and coagulation
biomarkers predict progression of chronic kidney disease?: SMART and ESPRIT --
Abstract |
Poster (with themed discussion) |
Slides
Peters L et al, The effect of IL-2 in HIV-1 patients with HBV/HCV co-infection.
Associations between fibrosis biomarkers at baseline and clinical outcomes: the
ESPRIT study --
Abstract |
Poster
Rodger A et al, Mortality in patients with well-controlled HIV and high CD4
counts in the cART arms of the SMART and ESPRIT randomized clinical trials
compared to the general population --
Abstract |
Poster
Rotger M et al, Contribution of genetic background to acute coronary artery
disease events in HIV-infected individuals: the MAGNIFICENT consortium --
Abstract |
Poster (with themed discussion) |
Slides
